In a randomized placebo-controlled, double-blinded trial, although liraglutide did not affect A load and cognition measures, 26 weeks of liraglutide treatment prevented expected decline of glucose metabolism that signifies cognitive impairment, synaptic dysfunction, and disease evolution (243)
Increased Energy Levels: IV drip therapy may contain B vitamins, amino acids, and other nutrients that support energy production and metabolism, helping to combat fatigue and improve overall energy levels
It may also aid fertility in women with PMOS
The dosage is increased in 2.5 mg increments every 4 weeks until reaching the maximum tolerated dose
We will contact you if this is the case, and you may opt out of the insurance at your own risk and discretion